India possesses a bigger share of the pie in contract research business as pharma market continues to grow in this region. If we study the figures we would get to know why India is the leader in this field. In terms of value it has business which is double that of Italy and four times as much of Spain.



What could be causing this? These is being caused by the direct presence of more than fifteen prominent contact research organizations operating in the country and have been attracted by the low cost R&D being offered by India.



MNCs moving to India are able to garner cost savings between thirty to fifty percent due to factors such as low wages, good equipment and IT support and an excellent supply of patients which could hasten up the clinical trial process.